| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,660 | 0,695 | 15:18 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | RAFFLES MEDICAL GROUP LTD: GENERAL ANNOUNCEMENT::CHANGES IN COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES | 3 | SGX Company Announcements | ||
| 01.04. | RAFFLES MEDICAL GROUP LTD: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-EXECUTIVE AND NON-INDEPENDENT DIRECTOR AS AUDIT & RISK COMMITTEE MEMBER | 1 | SGX Company Announcements | ||
| 01.04. | RAFFLES MEDICAL GROUP LTD: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF INDEPENDENT DIRECTOR - MR LIM SIM SENG | - | SGX Company Announcements | ||
| 01.04. | RAFFLES MEDICAL GROUP LTD: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF NON-EXECUTIVE AND NON-INDEPENDENT DIRECTOR - MR TAN SOO NAN | - | SGX Company Announcements | ||
| 01.04. | RAFFLES MEDICAL GROUP LTD: ANNUAL REPORTS AND RELATED DOCUMENTS | - | SGX Company Announcements | ||
| 01.04. | RAFFLES MEDICAL GROUP LTD: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| RAFFLES MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.03. | Raffles Medical CEO tightens grip with $0.99 share sweep | 2 | Singapore Business Review | ||
| 26.03. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::CHANGES IN INTEREST OF DIRECTOR - DR LOO CHOON YONG | 1 | SGX Company Announcements | ||
| 24.03. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::CHANGES IN INTEREST OF DIRECTOR - DR LOO CHOON YONG | 1 | SGX Company Announcements | ||
| 10.03. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::CHANGES IN INTEREST OF DIRECTOR - DR LU QINGHUI | - | SGX Company Announcements | ||
| 05.03. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::CHANGES IN INTEREST OF DIRECTOR - DR LOO CHOON YONG | 1 | SGX Company Announcements | ||
| 22.02. | RAFFLES MEDICAL GROUP LTD: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 2 | SGX Company Announcements | ||
| 22.02. | RAFFLES MEDICAL GROUP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | - | SGX Company Announcements | ||
| 09.02. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER - GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 1 | SGX Company Announcements | ||
| 16.01. | RAFFLES MEDICAL GROUP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE | 1 | SGX Company Announcements | ||
| 15.12.25 | RAFFLES MEDICAL GROUP LTD: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 5 | SGX Company Announcements | ||
| 11.12.25 | RAFFLES MEDICAL GROUP LTD: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | - | SGX Company Announcements | ||
| 09.12.25 | RAFFLES MEDICAL GROUP LTD: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 4 | SGX Company Announcements | ||
| 05.12.25 | RAFFLES MEDICAL GROUP LTD: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 03.12.25 | RAFFLES MEDICAL GROUP LTD: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 2 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 21,280 | 0,00 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| FRESENIUS MEDICAL CARE | 38,890 | -1,92 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 17,170 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| FRESENIUS | 44,620 | -0,51 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| SIEMENS HEALTHINEERS | 38,490 | +0,52 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| CARL ZEISS MEDITEC | 27,180 | +0,30 % | Carl Zeiss Meditec AG: Margendruck und strukturelle Unsicherheiten bestehen weiterhin. Kursziel gesenkt, HALTEN. | Die schwachen Ergebnisse von Carl Zeiss Meditec (CZM) für das erste Quartal des Geschäftsjahres 2025/26, die im Februar veröffentlicht wurden, sind weitgehend verarbeitet worden, jedoch schränkt der... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 46,040 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,600 | -0,64 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| GERRESHEIMER | 17,660 | +1,49 % | Gerresheimer verlässt den SDAX | ||
| HEARTFLOW | 29,020 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| DRAEGERWERK | 96,90 | -0,10 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| ESSILORLUXOTTICA | 203,80 | -1,21 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für EssilorLuxottica mit einem Kursziel von 320 Euro auf "Outperform" belassen. Wie Piral Dadhania am Dienstagabend in einem... ► Artikel lesen |